Skip to main content
. Author manuscript; available in PMC: 2013 Apr 19.
Published in final edited form as: CNS Neurosci Ther. 2011 Jun 7;18(4):285–294. doi: 10.1111/j.1755-5949.2011.00251.x

Table 1.

Study Study Type N Age Follow
up
N (%) szs EEG Seizure
Type
Treat-
ment
Risk factors and
relationship to
dementia stage
Pathology Methodological Issues
Sjorgren et al.
1952 [20]
Retrospective
autopsy study of
patients with AD
and Pick’s disease
18 53.0 ±
5.0
n/a 4 (22%) n/r n/r n/r All during late stage of
dementia
Yes Small sample size,
limited clinical
information available,
seizure diagnosis
uncertain
Letemendia et al. 1958 [64] Retrospective
autopsy series of
patients with AD
and EEGs
17 31-60 n/a 7 (41%) EEGs in all pts
with szs
3 (42%) had
IEDs
n/r n/r n/r Yes Small sample size,
early onset patients.
Sulkava et al. [7] Cross-sectional
study of
hospitalized AD
patients in one
center in Finland
71 35 AD
onset
before
age 65
n/a 6 (8%) All had 8 chan
EEG
IEDs not
reported
n/r n/r n/r No Diagnosis of epilepsy
not well characterized,
EEG findings not
described; not
assessed for other
potential causes of sz
Hauser et al.
1986 [8]
Retrospective
autopsy series of
AD patients in
Rochester, MN
83 n/r n/a 8 (9.6%) 5/8
had epilepsy
n/r “convulsiv
e” szs
(other sz
types not
assessed)
n/r Mean latency to first
sz was 6.5 from
dementia onset
Yes Retrospective, criteria
for sz diagnosis
unclear, assessed only
convulsive szs
Heyman et al.
1987 [22]
Prospective cohort
study of early
onset probable AD
patients at a single
center
92 62 (51
74)
1-6.8 yrs 13 (14%) n/r n/r n/r Szs occurred late in
course of dementia
Yes for 14 Diagnosis of epilepsy
not well characterized;
EEG findings not
described; limited
pathological
confirmation
Romanelli et al.
1990 [10]
Prospective case-
control study of
patients with mild
AD
44
(58 controls
)
71.5 ±
4.9
90 months 7 (16%) (vs. 0
in control
group)
EEG in 2 pts
only; IEDs seen
in both
All had
“GTC”
2 (29%)
pts noted
to have
focal
features
(Todd’s)
PHT All had advanced
dementia at time of
sz.
Yes for 3 EEG not performed; sz
diagnosis is
clinical/historical,
limited pathological
confirmation,
Risse et al. 1990
[9]
Prospective cohort
study of
hospitalized male
suspected AD
patients who had
autopsy
28 51-83 n/a 14 (64%) n/r n/r “most” patients treated 12 (86%) had szs
noted in last / of
illness;
Yes EEG not noted, sz
diagnosis not
specified, duration of
follow up not stated,
male only
Forstl et al. 1992
[21]
Prospective
autopsy series
56 75.4 ±
7.4
n/a 6 (10%) n/r n/r “generali
zed
motor
seizures”
in all
Szs in late stage of
disease
Yes. Patients
with szs
had cell
loss in
parietal
lobe and in
parahippoc
ampal
gyrus but
not in CA1
Limited details on
seizure diagnosis;
assessment via
historical information,
older onset group
McAreavey et al.
1992 [11]
Cross- sectional
retrospective
study o f
hospitalized
patients with
dementia in
Scotland
208 58-94 n/a 19 (9.1%) n/r 82 total sz
reported,
59 (72%)
2nd GTCs,
18 (22%)
CPS, 5
(6%) unclassifie
d
8(42%)
of pts
with szs
on AEDs
(PHT,
CBZ or
PB)
Sz patients younger
more impaired on
CAPE information/orientatio
n score, trend towards
lower MMSE scores
No Inpatients likely
represent more severe
disease type, no clear
criteria for making AD
diagnosis, ascertainment of
epilepsy/sz not clearly
defined
Mendez et al.
1994 [12]
Retrospective
autopsy series
from a brain bank
446 64.1 ±
8.8 (sz
group) 67.0 ±
9.8 (no
sz group)
n/a 77 (17%) 52 (67%) total
EEGs 39 ( 75%) with
focal slowing;
15 (29%) with
lEDs
69 (89%)
GTC; 9
(11%)
partial
65 (84%)
were on
AED
Younger age of onset
of AD compared to
age/sex matched non-
sz AD patients; mod-
advanced AD;
Yes. No neuropath- ological differences between pts with and without szs Not matched for AD
severity at time of sz
(only age of
onset/duration of
illness). Sz
ascertainment based
on historical
information, family
questionnaire
Volicer et al.
1995 [13]
Cross-sectional
study of
hospitalized
patients with
probable AD
75 70.6 ±
4.4
n/a 27 (36%) No discussion
of lEDs in
patients who
had EEGs
(number not
stated)
n/r 23 pts (85%) treated szs were associated
with worsening in
language function
Yes for 17
(63%)
No clear criteria for
diagnosing epilepsy;
variable disease
severity at onset,
incomplete
pathological
confirmation
Hesdorffer et al.
1996 [14]
Population-based
case-control study
Rochester, MN of
patients >55 yrs
with 1st
unprovoked sz;
compared to 2 age
matched controls
without szs at
time of diagnosis
145 55-94 n/a 17(11%) of
patients with
sz had AD
n/r 6 (3 5%)
AD pts
partial
onset sz
11 (65%)
AD pts
generalize
d onset sz
n/r szs occurred 3.3 (0.4
9.3) yrs from AD onset
No Sz diagnosis based on
historical data
Samson et al.
1996 [37]
Cross-sectional
population study
of patients with
probable early
onset AD
198 36-64 n/a 13 (7%) at
time of initial
AD diagnosis;
94 (45%) over
course of AD
n/r n/r n/r Presence of
myoclonus was
associated with a 7.7
RR of having szs.
No Retrospective, s z
diagnosis made from
chart only, criteria for
epilepsy diagnosis is
not clearly delineated
Lozsadi and
Larner 2006
[16]
Retrospective
cohort study,
single outpatient
dementia clinic
with clinical AD
diagnosis
177 49-84 n/a 12 (6.8%)
total; half had
szs felt to be
temporally
related to AD
onset
n/r All 6
(100%)
with
epilepsy
after AD
onset had
CPS, 1
(17%) nd with 2
GTC
n/r n/r No Clinical diagnosis,
retrospective, small
size, criteria for
epilepsy diagnosis is
not clearly delineated
Amatniek et al.
2006 [15]
Prospective cohort
study of mild
probable AD
patients from 3
centers
233 n/r 5.99 yrs
(0-8.95)
12 (7.75%). 135 (58%) had
EEG Focal IEDs in all
sz subset (9 sz
pts had EEGs)
n/r n/r Sz more common in
younger , African
American, more
severely demented
No EEGs not performed
on all patients. Sz
diagnosis by history,
chart review, clinical
impression;
incomplete information on many
patients; no age-
matched control
cohort (sz rates in
controls estimated
from literature)
Scarmeas et al.
2009 [18]
Prospective cohort
study of mild
probable AD from
3 centers
453 74.4±8.
9 yrs
3.9 yrs 7 (1.5%); 3
(0.7%) with
epilepsy
21 pts (5%)
had EEGs
3 of these
(16%) had
epileptiform
activity
GTC in 6
(86%)
Only 4
treated
Sz more common in
younger patients
Yes for 15 EEGs not performed
on all patients. Sz
diagnosis made by
review of chart -
patients; incomplete
information on many
patients. no age-
matched control
cohort (sz rates in
controls estimated
from literature)
Rao et al. 2009
[17]
Retrospective
cohort study of
dementia and MCI
outpatients in
single center AD
registry
1738 50-100 n/a 61 (3.6%) had
epilepsy
(sufficient
records on 31
[1.7%])
29 (72%) had
EEGs 15 (51%) had
IEDs
44 (72%)
had CPS
22 (36%)
had probable
remote
symptom
atic cause
for their
epilepsy
AEDs used: PHT, VPA, CBZ, GBP, PB,
CLZ; 79%
“excel
lent”
response
n/r No Retrospective,
included MCI and
patients with remote
symptomatic causes of
epilepsy predating
onset of cognitive
impairment. Not
controlled for disease
severity. Limited,
incomplete clinical
information
Bernardi et al.
2010 [19]
Retrospective
cohort study of
probable AD
patients at single
center
145 51-91 n/a 14 (9.7%)
with sz; 10
(6.9%) had
epilepsy
Incomplete
EEGs in non-szs
cohort; in sz
cohort 37.5%
had IEDs
13 (93%)
had CPS
with secondary
generaliza
tion
n/r Non-significant trend
for sz occurring in
more severe dementia
No Retrospective, sz
diagnosis based on
chart review

n/a: not applicable; n/r: not reported; AD: Alzheimer’s Disease; IED: interictal discharges; CPS: complex partial seizure; GTC: generalized tonic-clonic seizure; MCI: mild cognitive impairment; MID: multi-infarct dementia; 2nd GTC: secondarily generalized tonic-clonic seizure; Sz: seizure; PHT: phenytoin; CBZ: carbamazepine; CLZ: clonazepam; GPB: gabapentin; VPA: valproic acid; PB: Phenobarbital;